Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation

Microvascular Research

Volumn 79, Issue 3, 2010, Pages 200-206

  Tongers, Jörn ^a,b   Roncalli, Jerome G ^a,c   Losordo, Douglas W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Collateral formation; Endothelial progenitor cell; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; BONE MARROW MONONUCLEAR CELL; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; CLINICAL TRIAL; COLLATERAL CIRCULATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EPITHELIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MONONUCLEAR CELL; NERVE SPROUTING; NONHUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION; TISSUE REGENERATION;

ANIMALS; COLLATERAL CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

ANGINA; ANIMALIA;

EID: 77952091738     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.01.012     Document Type: Article

References (82)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
3. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
4. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
5. Boda Z., Udvardy M., Razso K., Farkas K., Toth J., Jambor L., Olah Z., Ilonczai P., Szarvas M., Kappelmayer J., Vereb Z., Rajnavolgyi E. Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger's disease. Clin. Appl. Thromb. Hemost. 2009, 15:552-560.
6. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
7. Carmeliet P., Luttun A. The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Thromb. Haemost. 2001, 86:289-297.
8. Carr A.N., Howard B.W., Yang H.T., Eby-Wilkens E., Loos P., Varbanov A., Qu A., DeMuth J.P., Davis M.G., Proia A., Terjung R.L., Peters K.G. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc. Res. 2006, 69:925-935.
9. Cohen M., Sherman W., Rentrop K.P., Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J. Am. Coll. Cardiol. 1989, 13:297-303.
10. Conway E.M., Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 2001, 49:507-521.
11. Curado S., Stainier D.Y. The HeArt of regeneration. Cell 2006, 127:462-464.
12. Deindl E., Zaruba M.M., Brunner S., Huber B., Mehl U., Assmann G., Hoefer I.E., Mueller-Hoecker J., Franz W.M. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006, 20:956-958.
13. Erbs S., Linke A., Schachinger V., Assmus B., Thiele H., Diederich K.W., Hoffmann C., Dimmeler S., Tonn T., Hambrecht R., Zeiher A.M., Schuler G. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 2007, 116:366-374.
14. Gibson C.M., Ryan K., Sparano A., Moynihan J.L., Rizzo M., Kelley M., Marble S.J., Laham R., Simons M., McClusky T.R., Dodge J.T. Angiographic methods to assess human coronary angiogenesis. Am. Heart J. 1999, 137:169-179.
15. Goodell M.A., Jackson K.A., Majka S.M., Mi T., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K. Stem cell plasticity in muscle and bone marrow. Ann. N. Y. Acad. Sci. 2001, 938:208-218. discussion 218-220.
16. Hansen J.F. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am. Heart J. 1989, 117:290-295.
17. He Z., Opland D.M., Way K.J., Ueki K., Bodyak N., Kang P.M., Izumo S., Kulkarni R.N., Wang B., Liao R., Kahn C.R., King G.L. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler. Thromb. Vasc. Biol 2006, 26:787-793.
18. Heil M., Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res. 2004, 95:449-458.
19. Heil M., Ziegelhoeffer T., Mees B., Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ. Res. 2004, 94:573-574.
20. Hillebrands J.L., Klatter F.A., van Dijk W.D., Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat. Med. 2002, 8:194-195.
21. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1584-1595.
22. Iwasaki H., Fukushima K., Kawamoto A., Umetani K., Oyamada A., Hayashi S., Matsumoto T., Ishikawa M., Shibata T., Nishimura H., Hirai H., Mifune Y., Horii M., Sugimura K., Suehiro S., Asahara T. Synchrotron radiation coronary microangiography for morphometric and physiological evaluation of myocardial neovascularization induced by endothelial progenitor cell transplantation. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1326-1333.
23. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:3422-3427.
24. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., Masaki H., Mori Y., Iba O., Tateishi E., Kosaki A., Shintani S., Murohara T., Imaizumi T., Iwasaka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046-1052.
25. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Amano K., Iba O., Imada T., Iwasaka T. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1804-1810.
26. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., Silver M., Ma H., Kearney M., Isner J.M., Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
27. Kawamoto A., Tkebuchava T., Yamaguchi J., Nishimura H., Yoon Y.S., Milliken C., Uchida S., Masuo O., Iwaguro H., Ma H., Hanley A., Silver M., Kearney M., Losordo D.W., Isner J.M., Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461-468.
28. Kawamoto A., Murayama T., Kusano K., Ii M., Tkebuchava T., Shintani S., Iwakura A., Johnson I., von Samson P., Hanley A., Gavin M., Curry C., Silver M., Ma H., Kearney M., Losordo D.W. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 2004, 110:1398-1405.
29. Kawamoto A., Iwasaki H., Kusano K., Murayama T., Oyamada A., Silver M., Hulbert C., Gavin M., Hanley A., Ma H., Kearney M., Zak V., Asahara T., Losordo D.W. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006, 114:2163-2169.
30. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 2004, 94:678-685.
31. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
32. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
33. Koerselman J., van der Graaf Y., de Jaegere P.P., Grobbee D.E. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003, 107:2507-2511.
34. Koerselman J., de Jaegere P.P., Verhaar M.C., van der Graaf Y., Grobbee D.E. High blood pressure is inversely related with the presence and extent of coronary collaterals. J. Hum. Hypertens 2005, 19:809-817.
35. Korf-Klingebiel M., Kempf T., Sauer T., Brinkmann E., Fischer P., Meyer G.P., Ganser A., Drexler H., Wollert K.C. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur. Heart J. 2008, 29:2851-2858.
36. Kudo F.A., Nishibe T., Nishibe M., Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int. Angiol. 2003, 22:344-348.
37. Lambiase P.D., Edwards R.J., Anthopoulos P., Rahman S., Meng Y.G., Bucknall C.A., Redwood S.R., Pearson J.D., Marber M.S. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004, 109:2986-2992.
38. Landmesser U., Hornig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109:II27-II33.
39. Lepilina A., Coon A.N., Kikuchi K., Holdway J.E., Roberts R.W., Burns C.G., Poss K.D. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006, 127:607-619.
40. Lerman A., Zeiher A.M. Endothelial function: cardiac events. Circulation 2005, 111:363-368.
41. Lev E.I., Kleiman N.S., Birnbaum Y., Harris D., Korbling M., Estrov Z. Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J. Vasc. Res. 2005, 42:408-414.
42. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004, 109:2692-2697.
43. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., Poh K.K., Weinstein R., Kearney M., Chaudhry M., Burg A., Eaton L., Heyd L., Thorne T., Shturman L., Hoffmeister P., Story K., Zak V., Dowling D., Traverse J.H., Olson R.E., Flanagan J., Sodano D., Murayama T., Kawamoto A., Kusano K.F., Wollins J., Welt F., Shah P., Soukas P., Asahara T., Henry T.D. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
44. Losordo D.W., Henry T., Schatz R.A., Lee J.S., Costa M., Bass T., Schaer G., Niederman A., Mendelsohn F., Davidson C., Waksman R., Soukas P.A., Simon D., Chronos N., Fortuin F.D., Huang P.P., Weintraub N., Yeung A., Rosenfield K., Wong S.C., Taussig A., Rava A.N., Sherman W., Kereiakes D., Strumpf R.K., Port S., Pieper K., Adams P.X., Harrington R. Abstract 5638: Autologous CD34+ cell therapy for refractory angina: 12 month results of the phase II ACT34-CMI study. Circulation 2009, 120:S1132-a-.
45. Masuda H., Kalka C., Takahashi T., Yoshida M., Wada M., Kobori M., Itoh R., Iwaguro H., Eguchi M., Iwami Y., Tanaka R., Nakagawa Y., Sugimoto A., Ninomiya S., Hayashi S., Kato S., Asahara T. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ. Res. 2007, 101:598-606.
46. Matsuo Y., Imanishi T., Hayashi Y., Tomobuchi Y., Kubo T., Hano T., Akasaka T. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. Intern. Med. 2006, 45:581-587.
47. Mouquet F., Cuilleret F., Susen S., Sautiere K., Marboeuf P., Ennezat P.V., McFadden E., Pigny P., Richard F., Hennache B., Vantyghem M.C., Bertrand M., Dallongeville J., Jude B., Van Belle E. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur. Heart J. 2009, 30:840-849.
48. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
49. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci. 2001, 938:221-229. discussion 229-230.
50. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
51. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., Funahashi T., Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 2004, 279:1304-1309.
52. Pohl T., Seiler C., Billinger M., Herren E., Wustmann K., Mehta H., Windecker S., Eberli F.R., Meier B. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J. Am. Coll. Cardiol. 2001, 38:1872-1878.
53. Poss K.D., Wilson L.G., Keating M.T. Heart regeneration in zebrafish. Science 2002, 298:2188-2190.
54. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
55. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
56. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J. Am. Coll. Cardiol. 1985, 5:587-592.
57. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
58. Sasayama S., Fujita M. Recent insights into coronary collateral circulation. Circulation 1992, 85:1197-1204.
59. Schaper W., Ito W.D. Molecular mechanisms of coronary collateral growth. Circ. Res. 1996, 79:911-919.
60. Schaper W., Scholz D. Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1143-1151.
61. Schaper W., Sharma H.S., Quinkler W., Markert T., Wunsch M., Schaper J. Molecular biologic concepts of coronary anastomoses. J. Am. Coll. Cardiol. 1990, 15:513-518.
62. Schierling W., Troidl K., Troidl C., Schmitz-Rixen T., Schaper W., Eitenmuller I.K. The role of angiogenic growth factors in arteriogenesis. J. Vasc. Res. 2009, 46:365-374.
63. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
64. Shintani S., Murohara T., Ikeda H., Ueno T., Sasaki K., Duan J., Imaizumi T. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103:897-903.
65. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K., Shimada T., Oike Y., Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
66. Simons M. Angiogenesis: where do we stand now?. Circulation 2005, 111:1556-1566.
67. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
68. Troidl K., Ruding I., Cai W.J., Mucke Y., Grossekettler L., Piotrowska I., Apfelbeck H., Schierling W., Volger O.L., Horrevoets A.J., Grote K., Schmitz-Rixen T., Schaper W., Troidl C. Actin-binding rho activating protein (Abra) is essential for fluid shear stress-induced arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2093-2101.
69. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004, 95:343-353.
70. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003, 108:2511-2516.
71. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
72. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 2001, 49:554-560.
73. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D.W., Asahara T., Isner J.M. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
74. Werner G.S., Ferrari M., Betge S., Gastmann O., Richartz B.M., Figulla H.R. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 2001, 104:2784-2790.
75. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 2003, 93:e17-24.
76. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ. Res. 2005, 96:151-163.
77. Wustmann K., Zbinden S., Windecker S., Meier B., Seiler C. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?. Circulation 2003, 107:2213-2220.
78. Xiang G., Schuster M.D., Seki T., Kocher A.A., Eshghi S., Boyle A., Itescu S. Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors. J. Exp. Med. 2004, 200:1657-1666.
79. Yamamoto K., Takahashi T., Asahara T., Ohura N., Sokabe T., Kamiya A., Ando J. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol. 2003, 95:2081-2088.
80. Ye C., Bai L., Yan Z.Q., Wang Y.H., Jiang Z.L. Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt. Clin. Biomech. (Bristol, Avon) 2008, 23(Suppl. 1):S118-S124.
81. Zhou B., Bi Y.Y., Han Z.B., Ren H., Fang Z.H., Yu X.F., Poon M.C., Han Z.C. G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability. J. Thromb. Haemost. 2006, 4:993-1002.
82. Ziegelhoeffer T., Fernandez B., Kostin S., Heil M., Voswinckel R., Helisch A., Schaper W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004, 94:230-238.